SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000895421-17-000400
Filing Date
2017-09-22
Accepted
2017-09-22 16:08:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 MS INITIAL noveliontherapeutics.txt SC 13G 15454
  Complete submission text file 0000895421-17-000400.txt   17564
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Subject) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43381 | Film No.: 171097736
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1585 BROADWAY NEW YORK NY 10036
Business Address 1585 BROADWAY NEW YORK NY 10036 212-761-4000
MORGAN STANLEY (Filed by) CIK: 0000895421 (see all company filings)

IRS No.: 363145972 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies